Importantly, high expression of PSAT1 was significantly associated with poorer overall survival in DLBCL (Figure 5E), with a trend toward patients with high expression of PHGDH also having reduced overall survival. The gene discussed is PSAT1; the disease is diffuse large B-cell lymphoma.